Solid Biosciences Inc. — Director's Dealing 2022

Feb 1, 2022

SEC Form 4/A — Form 4/A

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-01-27

Reporting Person: Brennan Erin Powers (Chief Legal Officer, Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-27	Restricted Stock Units	$	A	81250	Acquired		Common Stock (81250)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.

F2: This amendment to the Form 4 filed on January 31, 2022 (the "Original Form 4") is being filed to correct the vesting information on a transaction reported on the Original Form 4. The restricted stock units were granted on January 27, 2022 and vest on the second anniversary of the grant date.